|
DIS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.943700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.083780E-03 |
| Normal-vs-Stage2 |
5.951400E-01 |
| Normal-vs-Stage3 |
1.060550E-01 |
| Normal-vs-Stage4 |
5.784100E-03 |
| Stage1-vs-Stage2 |
2.884000E-01 |
| Stage1-vs-Stage3 |
6.727400E-01 |
| Stage1-vs-Stage4 |
6.967000E-01 |
| Stage2-vs-Stage3 |
5.692000E-01 |
| Stage2-vs-Stage4 |
2.463000E-01 |
| Stage3-vs-Stage4 |
5.012600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.278700E-03 |
| Normal-vs-AfricanAmerican |
3.353700E-02 |
| Normal-vs-Asian |
1.122830E-03 |
| Caucasian-vs-AfricanAmerican |
9.060400E-01 |
| Caucasian-vs-Asian |
5.975900E-02 |
| AfricanAmerican-vs-Asian |
6.781600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.376200E-04 |
| Normal-vs-Female |
6.850000E-01 |
| Male-vs-Female |
2.365500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.979600E-03 |
| Normal-vs-Extreme_Weight |
9.78149999999456E-05 |
| Normal-vs-Obese |
3.877400E-01 |
| Normal-vs-Extreme_Obese |
8.799900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.199200E-01 |
| Normal_Weight-vs-Obese |
1.070360E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.004600E-01 |
| Extreme_Weight-vs-Obese |
1.634210E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.807000E-01 |
| Obese-vs-Extreme_Obese |
2.615800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.540400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.504400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.424600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.272100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.556600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.379200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.696600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.820200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.047190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.507800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.084620E-03 |
| Normal-VS-Type2 PRCC |
1.855770E-02 |
| Normal-VS-KIRP CIMP |
5.899600E-02 |
| Normal-VS-Unclassified PRCC |
6.742800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.743800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.702000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.905560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.226400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.424000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.579600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.21119999999475E-05 |
| Normal-vs-N1 |
3.817800E-01 |
| Normal-vs-N2 |
8.242400E-04 |
| N0-vs-N1 |
5.167700E-02 |
| N0-vs-N2 |
3.786000E-01 |
| N1-vs-N2 |
1.253040E-01 |
|
|
